4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000069
Director sold 6,250 shares at an average $116.28 ($726,731)
- Director acquired 6,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loxam Teri Director | 2024-09-17 | Option exercise 10b5-1 | +6,250 | $22.70 | $141,875 | 13,425 | D |
| Loxam Teri Director | 2024-09-17 | Sale 10b5-1 | −241 | $114.64 | $27,628 | 13,184 | D |
| Loxam Teri Director | 2024-09-17 | Sale 10b5-1 | −1,445 | $115.32 | $166,634 | 11,739 | D |
| Loxam Teri Director | 2024-09-17 | Sale 10b5-1 | −4,308 | $116.62 | $502,387 | 7,431 | D |
| Loxam Teri Director | 2024-09-17 | Sale 10b5-1 | −256 | $117.51 | $30,083 | 7,175 | D |
| Derivatives | |||||||
| Loxam Teri Director | 2024-09-17 | Option exercise · Stock Option (right to buy) 10b5-1 | −6,250 | 12,500 | D | ||
| Open-market sales · 6,250 sh · avg $116.28 · $726,731 | |||||||
Loading xslF345X05/wk-form4_1726691078.xml…